Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Natural History Study for Patients With Nemaline Myopathy in Belgium

NCT: NCT07201636 · NOT_YET_RECRUITING

NCT IDNCT07201636
StatusNOT_YET_RECRUITING
Start Date2026-08
Completion2029-08

Brief Summary

This is a prospective, longitudinal, observational study designed to characterize the natural history of Nemaline Myopathy (NM), a rare congenital neuromuscular disorder. The study will follow up to 10 participants of any age with genetically confirmed NM over a period of three years. Data will be collected during routine annual hospital visits and include clinical, motor, respiratory, and quality-of-life assessments. The goal is to improve clinical trial readiness by identifying disease-specific outcome measures and potential biomarkers.

Frequently Asked Questions

What is Natural History Study for Patients With Nemaline Myopathy in Belgium?

Natural History Study for Patients With Nemaline Myopathy in Belgium is a clinical trial registered under NCT07201636. Current status: NOT_YET_RECRUITING.

What is the status of NCT07201636?

The current status of NCT07201636 (Natural History Study for Patients With Nemaline Myopathy in Belgium) is: NOT_YET_RECRUITING.

When did Natural History Study for Patients With Nemaline Myopathy in Belgium start?

Natural History Study for Patients With Nemaline Myopathy in Belgium started on 2026-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.